Craig Naugle, MD
MOHS-Micrographic Surgery · Springfield, MONPI 1104805381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 28.9% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in MO, where the typical reported total is $3,755.
Across 111 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$592
- Novartis$215
- UCB, Inc.$198
- Genentech USA, Inc.$173
- Sun Pharmaceutical Industries Inc.$164
- LEO Pharma Inc.$94
- plus $613 from 14 others
What the payments were for
- Food & beverage$2,049100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $592 |
| Novartis | 11 | $215 |
| UCB, Inc. | 9 | $198 |
| Genentech USA, Inc. | 7 | $173 |
| Sun Pharmaceutical Industries Inc. | 7 | $164 |
| LEO Pharma Inc. | 5 | $94 |
| Regeneron Healthcare Solutions, Inc. | 5 | $83 |
| Lilly USA, LLC | 5 | $77 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Pfizer | 5 | $74 |
| Incyte Corporation | 4 | $71 |
| Johnson & Johnson | 3 | $56 |
| Fresenius Kabi USA, LLC | 2 | $35 |
| Almirall LLC | 2 | $34 |
| Mayne Pharma Commercial LLC | 2 | $27 |
| Galderma Laboratories, L.p. | 2 | $27 |
| Organogenesis Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Merck | 1 | $13 |
| Strata Skin Sciences, Inc. | 1 | $12 |
How this compares
$2,049 in reported general payments places this provider in the 25th percentile of 27 mohs-micrographic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 152 | $1,167 |
| Imiquimod | 11 | $440 |
| Mupirocin | 45 | $351 |
| Clobetasol Propionate | 14 | $340 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Springfield
- Michael SwannSpringfield$6K
- Brett NeillSpringfield$2K
- Meghan SeagoSpringfield$613
- Mark KoryChesterfield$180K
- Ronald WheelandColumbia$109K
- Martha CouncilSaint Louis$38K
- Basia Michalski-McneelySaint Louis$12K
- Lindall PerryColumbia$11K
- Mark CohenKansas City$10K
- Katherine GlaserHannibal$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.